Dendritic Cell Vaccine for Patients With Brain Tumors

Clinical trial NCT01204684 · COMPLETED

Trial details

NCT number: NCT01204684
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioma Anaplastic Astrocytoma Anaplastic Astro-oligodendroglioma Glioblastoma

Start date: 2010-10-08
Primary completion: 2024-08-21
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.